Selected data models

You must log in to select data models for download or further analysis.

13 Search results.
Relevance Rating New first Old first

Vital Signs and Physical Examination 12- Weeks Visits SirTac NCT02936388 - Vital Signs and Physical Examination 12- Weeks Visits

- 12/3/17 - 1 form, 2 itemgroups, 31 items, 1 language
Itemgroups: vital signs, Physical Examination
Study part: Vital Signs and Physical Examination 12- Weeks Visits. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Vital Signs and Physical Examination 3- Weeks Visits SirTac NCT02936388 - Vital Signs and Physical Examination 3- Weeks Visits

- 12/3/17 - 1 form, 2 itemgroups, 31 items, 1 language
Itemgroups: vital signs, Physical Examination
Study part: Vital Signs and Physical Examination 3- Weeks Visits. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Vital Signs and Physical Examination 6- Weeks Visits SirTac NCT02936388 - Vital Signs and Physical Examination 6- Weeks Visits

- 12/3/17 - 1 form, 2 itemgroups, 31 items, 1 language
Itemgroups: vital signs, Physical Examination
Study part: Vital Signs and Physical Examination 6- Weeks Visits. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Vital Signs and Physical Examination End of Therapy SirTac NCT02936388 - Vital Signs and Physical Examination End of Therapy

- 11/28/17 - 1 form, 2 itemgroups, 31 items, 1 language
Itemgroups: vital signs, Physical Examination
Study part: Vital Signs and Physical Examination End of Therapy. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Medical History Visit 08 SirTac NCT02936388 - Medical History Visit 08

- 11/26/17 - 1 form, 2 itemgroups, 11 items, 1 language
Itemgroups: Visit, quality of life
Study part: Medical History Visit 08. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Vital Signs and Physical Examination Visit 07 SirTac NCT02936388 - Vital Signs and Physical Examination Visit 07

- 11/26/17 - 1 form, 2 itemgroups, 31 items, 1 language
Itemgroups: vital signs, Physical Examination
Study part: Vital Signs and Physical Examination Visit 07. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Vital Signs and Physical Examination Visit 06 SirTac NCT02936388 - Vital Signs and Physical Examination Visit 06

- 11/26/17 - 1 form, 2 itemgroups, 31 items, 1 language
Itemgroups: vital signs, Physical Examination
Study part: Vital Signs and Physical Examination Visit 06. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Vital Signs and Physical Examination Visit 03 SirTac NCT02936388 - Vital Signs and Physical Examination Visit 03

- 11/26/17 - 1 form, 2 itemgroups, 31 items, 1 language
Itemgroups: vital signs, Physical Examination
Study part: Vital Signs and Physical Examination Visit 03. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Vital Signs and Physical Examination Before every SIRT- or TACE- Treatment SirTac NCT02936388 - Vital Signs and Physical Examination Before every SIRT- or TACE- Treatment

- 11/26/17 - 1 form, 2 itemgroups, 31 items, 1 language
Itemgroups: vital signs, Physical Examination
Study part: Vital Signs and Physical Examination Before every SIRT- or TACE- Treatment. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Vital Signs and Physical Examination Screening Day -14 to 0 SirTac NCT02936388 - Vital Signs and Physical Examination Screening Day -14 to 0

- 11/26/17 - 1 form, 2 itemgroups, 33 items, 1 language
Itemgroups: vital signs, Physical Examination
Study part: Vital Signs and Physical Examination Screening Day -14 to 0. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Vital Signs and ECOG Screening Day -7 to 0 SirTac NCT02936388 - Vital Signs and ECOG Screening Day -7 to 0

- 11/26/17 - 1 form, 2 itemgroups, 18 items, 1 language
Itemgroups: vital signs, quality of life
Study part: Vital Signs and ECOG Screening Day -7 to 0. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Vital Signs and ECOG Screening Day -7 to 0 SirTac NCT02936388 - Vital Signs and ECOG Screening Day -7 to 0

- 11/20/17 - 1 form, 2 itemgroups, 18 items, 1 language
Itemgroups: vital signs, quality of life
Study part: Vital Signs and ECOG Screening Day -7 to 0. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial